McKesson Corporation $MCK Shares Sold by Park National Corp OH

Park National Corp OH trimmed its holdings in McKesson Corporation (NYSE:MCK) by 13.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,604 shares of the company’s stock after selling 2,072 shares during the period. Park National Corp OH’s holdings in McKesson were worth $11,159,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in MCK. GAMMA Investing LLC raised its holdings in McKesson by 5.8% in the fourth quarter. GAMMA Investing LLC now owns 4,372 shares of the company’s stock valued at $3,586,000 after acquiring an additional 241 shares in the last quarter. Jacobs & Co. CA acquired a new position in McKesson during the 4th quarter worth $205,000. Triumph Capital Management acquired a new position in McKesson during the 3rd quarter worth $179,000. AIA Group Ltd bought a new stake in shares of McKesson in the 3rd quarter worth about $322,000. Finally, Strategic Investment Advisors MI increased its position in shares of McKesson by 1.7% in the 3rd quarter. Strategic Investment Advisors MI now owns 901 shares of the company’s stock worth $696,000 after purchasing an additional 15 shares during the last quarter. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. Wall Street Zen lowered McKesson from a “buy” rating to a “hold” rating in a report on Saturday, March 14th. Raymond James Financial set a $970.00 target price on McKesson in a report on Thursday, March 5th. Mizuho lifted their target price on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Finally, Weiss Ratings downgraded McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. Thirteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, McKesson presently has a consensus rating of “Moderate Buy” and an average target price of $960.93.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Michele Lau sold 2,725 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the sale, the executive vice president directly owned 3,247 shares in the company, valued at approximately $3,214,530. This trade represents a 45.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Leann B. Smith sold 190 shares of the business’s stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total transaction of $179,550.00. Following the transaction, the executive vice president directly owned 2,989 shares of the company’s stock, valued at approximately $2,824,605. This trade represents a 5.98% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 3,868 shares of company stock worth $3,743,820. 0.08% of the stock is owned by company insiders.

McKesson Stock Down 2.3%

Shares of NYSE:MCK opened at $898.82 on Friday. The company has a market cap of $110.10 billion, a PE ratio of 25.85, a P/E/G ratio of 1.48 and a beta of 0.38. McKesson Corporation has a fifty-two week low of $637.00 and a fifty-two week high of $999.00. The firm has a 50-day simple moving average of $902.24 and a 200 day simple moving average of $831.10.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. The firm had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. McKesson’s revenue was up 11.4% on a year-over-year basis. During the same quarter last year, the company posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, research analysts forecast that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be given a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s payout ratio is currently 9.43%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.